WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 76'9601 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 88'3181 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 524  516  508  498  487  436  382  364 
Births
Surviving infants
Pop. less than 5 years 30  29  29  28  28  28  23  21 
Pop. less than 15 years 92  91  90  89  88  83  66  68 
Female 15-49 years 129  128  127  124  121  109  97  91 

Number of reported case

(Click for retrospective incidence data for Luxembourg)
Diphtheria
Japanese encephalitis
Measles 16  63 
Mumps 25  26 
Pertussis 10  46 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Luxembourg)
Vaccine year result method % card seen                                                
BCG         
DTP1          100  100  100  100 
DTP3          99  99  99  99  90 
HepB_BD         
HepB3          95  95  95  94 
Hib3          99  99  99  98 
JapEnc         
MCV          96  96  96  96  80 
MCV2         
PCV1          95  95  95  95 
PCV3          86  86  86  86 
Pol3          99  99  99  99  90 
Rota1         
Rota_last         
Rubella1          96  96  96  96 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Luxembourg)
DTP1 99  99  99  99  99  98  96 
DTP3 99  99  99  99  99  98  90 
HepB3 95  95  94  95  94  49 
Hib3 99  99  98  99  98  91 
MCV 96  96  96  96  96  91  80 
PCV3 86  86  86  86  86 
Pol3 99  99  99  99  99  98  90 
Rota_last 86  86  86  86 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 2, 3, 13 months; Yes
DTaPHibIPV 4 months; Yes
DTaPIPV 5-6 years; 15-16 years; Yes every 10 years as a booster
HPV 12-18 years; Yes
Influenza >=65 years; Yes and certain chronic diseases
MMRV 12, 15-23 months;
MenC_conj 13 months; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 60 years; Yes
Rotavirus 2, 3 months; Yes
Typhoid Yes travelers
YF Yes travelers

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR NA  NA  NA  NA  NA  NA  NA 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number NA  NA  NA  NA  NA  NA   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number   NA  NA   
Nº districts with DTP3 coverage >=80% number              
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%       100  100  100   

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.